uti | UroPharma

New opportunities in bladder treatments.

As part of UroPharma’s development, Urinary Tract Infections are a main focal point. We are please to post our joint collaboration...

New Bladder therapies to ease the suffering of millions by simply changing clinical practice.

UroPharma’s dtb-Instilla Intermittent will: aid the fight against anti-microbial resistance, Urinary Tract Infections and address the...

Benefits of Direct-to-Bladder drug targeting.

Quality of Life is a priority for healthcare professionals. Direct-to-Bladder therapies by UroPharma go a long way towards achieving best...

Direct to Bladder Therapies

About UroPharma UroPharma has patented and developed the world’s first licensed ‘direct to bladder’ drug delivery system, that will be in...